Advanced Biomed (ADVB) Research & Development (2023 - 2026)

Advanced Biomed has disclosed Research & Development across 4 years of filings, most recently posting $243226.0 for Q1 2026.

• Research & Development for Q1 2026 came in at $243226.0, up 10.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $975264.0 (up 18.48% YoY), and the FY2025 annual result was $909771.0, up 3.36% from the prior year.
• Research & Development came in at $243226.0 for Q1 2026 at Advanced Biomed, up from $186331.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $313509.0 in Q1 2024 to a low of $181703.0 in Q3 2024.
• The 4-year median for Research & Development is $216181.5 (2024), against an average of $230033.8.
• Peak annual rise in Research & Development reached 48.11% in 2025, while the deepest fall reached 29.84% in 2025.
• Advanced Biomed's Research & Development stood at $188387.0 in 2023, then increased by 12.75% to $212397.0 in 2024, then decreased by 12.27% to $186331.0 in 2025, then soared by 30.53% to $243226.0 in 2026.
• The last three Research & Development figures came in at $243226.0 (Q1 2026), $186331.0 (Q4 2025), and $235992.0 (Q3 2025), per Business Quant data.